AOD-9604: What the Research Shows

Research Use Only: This article summarises published scientific literature for laboratory and research audiences. It is not medical advice, and AOD-9604 is not approved for human or veterinary use.

What is AOD-9604?

AOD-9604 is a synthetic peptide corresponding to a modified fragment (amino acids 176-191) of the C-terminus of human growth hormone. It is studied in the research literature for lipid-metabolism pathways and is examined as a fragment distinct from the growth-promoting activity of the full hormone.

Where AOD-9604 sits in the research literature

The evidence base is largely preclinical, based on cell and animal studies of fat metabolism. Laboratory findings should not be extrapolated to people.

Reported areas of preclinical interest

• Lipid metabolism: studied for effects on lipolysis and fat-metabolism pathways in laboratory models, including beta-3 adrenergic-receptor-associated pathways.
• Growth-hormone fragment biology: examined as a C-terminal fragment separate from full growth-hormone activity.

Why the “research use only” label matters

AOD-9604 is supplied as a research material and is intended strictly for laboratory and scientific research, not for human or veterinary consumption.

Handling and storage

Store lyophilised peptide cool, dry and away from light, and refrigerate reconstituted solution, using it within the indicated stability window. Follow the documentation supplied with each batch.

Frequently asked questions

What is AOD-9604 studied for?

It is studied in laboratory models of lipid metabolism as a growth-hormone fragment.

Is AOD-9604 approved for human use?

No. It is a research material only and is not intended for human or veterinary use.

Key takeaways

AOD-9604 is a modified growth-hormone C-terminal fragment studied in preclinical lipid-metabolism research. It is a research material only. Review the AOD-9604 research product.

References

References sourced via PubMed.

1. Heffernan M, Summers RJ, Thorburn A, et al. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta3-AR knock-out mice. Endocrinology. 2001;142(12):5182-5189. DOI · PubMed 11713213.

Disclaimer: This article is for informational and educational purposes for a research audience. It is not medical advice. Products referenced are sold strictly for laboratory research and are not for human or veterinary use.